Will Dixon
Will Dixon
Verified email at manchester.ac.uk - Homepage
Title
Cited by
Cited by
Year
Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy …
WG Dixon, K Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons
Arthritis & Rheumatism: Official Journal of the American College of …, 2006
8632006
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
WG Dixon, KL Hyrich, KD Watson, M Lunt, J Galloway, A Ustianowski, ...
Annals of the rheumatic diseases 69 (3), 522-528, 2010
7542010
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results …
JB Galloway, KL Hyrich, LK Mercer, WG Dixon, B Fu, AP Ustianowski, ...
Rheumatology 50 (1), 124-131, 2011
6552011
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: results from the British Society …
WG Dixon, KD Watson, M Lunt, KL Hyrich, AJ Silman, DPM Symmons
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
6482007
Serious infection following anti–tumor necrosis factor α therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies
WG Dixon, DPM Symmons, M Lunt, KD Watson, KL Hyrich, AJ Silman
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
3442007
Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
WG Dixon, M Abrahamowicz, ME Beauchamp, DW Ray, S Bernatsky, ...
Annals of the rheumatic diseases 71 (7), 1128-1133, 2012
2722012
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics …
MJ Harrison, WG Dixon, KD Watson, Y King, R Groves, KL Hyrich, ...
Annals of the rheumatic diseases 68 (2), 209-215, 2009
2552009
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an …
C Strehl, JWJ Bijlsma, M De Wit, M Boers, N Caeyers, M Cutolo, ...
Annals of the rheumatic diseases 75 (6), 952-957, 2016
2232016
Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for …
WG Dixon, KD Watson, M Lunt, LK Mercer, ...
Arthritis care & research 62 (6), 755-763, 2010
2122010
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology …
WG Dixon, KL Hyrich, KD Watson, M Lunt, DPM Symmons, ...
Annals of the rheumatic diseases 69 (6), 1086-1091, 2010
2042010
Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank
JM Lane, I Vlasac, SG Anderson, SD Kyle, WG Dixon, DA Bechtold, S Gill, ...
Nature communications 7 (1), 1-10, 2016
1962016
Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register
JB Galloway, KL Hyrich, LK Mercer, WG Dixon, AP Ustianowski, M Helbert, ...
Annals of the rheumatic diseases 70 (10), 1810-1814, 2011
1892011
A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries
JR Curtis, A Jain, J Askling, SL Bridges Jr, L Carmona, W Dixon, A Finckh, ...
Seminars in arthritis and rheumatism 40 (1), 2-14. e1, 2010
1822010
Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative
A Baillet, L Gossec, L Carmona, M de Wit, Y van Eijk-Hustings, ...
Annals of the rheumatic diseases 75 (6), 965-973, 2016
1732016
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology …
JB Galloway, LK Mercer, A Moseley, WG Dixon, AP Ustianowski, ...
Annals of the rheumatic diseases 72 (2), 229-234, 2013
1702013
European biologicals registers: methodology, selected results and perspectives
A Zink, J Askling, WG Dixon, L Klareskog, AJ Silman, DPM Symmons
Annals of the rheumatic diseases 68 (8), 1240-1246, 2009
1702009
The association between systemic glucocorticoid therapy and the risk of infection in patients with rheumatoid arthritis: systematic review and meta-analyses
WG Dixon, S Suissa, M Hudson
Arthritis research & therapy 13 (4), 1-14, 2011
1692011
What effects might anti-TNFα treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFα in cardiovascular …
WG Dixon, DPM Symmons
Annals of the rheumatic diseases 66 (9), 1132-1136, 2007
1562007
Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature
E Nikiphorou, H Radner, K Chatzidionysiou, C Desthieux, C Zabalan, ...
Arthritis research & therapy 18 (1), 1-11, 2016
1482016
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
LK Mercer, M Lunt, ALS Low, WG Dixon, KD Watson, DPM Symmons, ...
Annals of the rheumatic diseases 74 (6), 1087-1093, 2015
1442015
The system can't perform the operation now. Try again later.
Articles 1–20